882 related articles for article (PubMed ID: 28978426)
1. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
Kootte RS; Levin E; Salojärvi J; Smits LP; Hartstra AV; Udayappan SD; Hermes G; Bouter KE; Koopen AM; Holst JJ; Knop FK; Blaak EE; Zhao J; Smidt H; Harms AC; Hankemeijer T; Bergman JJGHM; Romijn HA; Schaap FG; Olde Damink SWM; Ackermans MT; Dallinga-Thie GM; Zoetendal E; de Vos WM; Serlie MJ; Stroes ESG; Groen AK; Nieuwdorp M
Cell Metab; 2017 Oct; 26(4):611-619.e6. PubMed ID: 28978426
[TBL] [Abstract][Full Text] [Related]
2. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
Holster S; Lindqvist CM; Repsilber D; Salonen A; de Vos WM; König J; Brummer RJ
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00034. PubMed ID: 31009405
[TBL] [Abstract][Full Text] [Related]
4. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome.
van der Vossen EWJ; Bastos D; Stols-Gonçalves D; de Goffau MC; Davids M; Pereira JPB; Li Yim AYF; Henneman P; Netea MG; de Vos WM; de Jonge W; Groen AK; Nieuwdorp M; Levin E
Gut Microbes; 2021; 13(1):1993513. PubMed ID: 34747338
[TBL] [Abstract][Full Text] [Related]
5. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome.
Hartstra AV; Schüppel V; Imangaliyev S; Schrantee A; Prodan A; Collard D; Levin E; Dallinga-Thie G; Ackermans MT; Winkelmeijer M; Havik SR; Metwaly A; Lagkouvardos I; Nier A; Bergheim I; Heikenwalder M; Dunkel A; Nederveen AJ; Liebisch G; Mancano G; Claus SP; Benítez-Páez A; la Fleur SE; Bergman JJ; Gerdes V; Sanz Y; Booij J; Kemper E; Groen AK; Serlie MJ; Haller D; Nieuwdorp M
Mol Metab; 2020 Dec; 42():101076. PubMed ID: 32916306
[TBL] [Abstract][Full Text] [Related]
6. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.
Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH
Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284
[TBL] [Abstract][Full Text] [Related]
9. Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome.
Smits LP; Kootte RS; Levin E; Prodan A; Fuentes S; Zoetendal EG; Wang Z; Levison BS; Cleophas MCP; Kemper EM; Dallinga-Thie GM; Groen AK; Joosten LAB; Netea MG; Stroes ESG; de Vos WM; Hazen SL; Nieuwdorp M
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581220
[TBL] [Abstract][Full Text] [Related]
10. Allogenic Faecal Microbiota Transfer Induces Immune-Related Gene Sets in the Colon Mucosa of Patients with Irritable Bowel Syndrome.
Holster S; Hooiveld GJ; Repsilber D; Vos WM; Brummer RJ; König J
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31597320
[TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial.
Yu EW; Gao L; Stastka P; Cheney MC; Mahabamunuge J; Torres Soto M; Ford CB; Bryant JA; Henn MR; Hohmann EL
PLoS Med; 2020 Mar; 17(3):e1003051. PubMed ID: 32150549
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans.
Staley C; Khoruts A; Sadowsky MJ
Arch Med Res; 2017 Nov; 48(8):766-773. PubMed ID: 29183720
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
14. Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review.
Zhang Z; Mocanu V; Cai C; Dang J; Slater L; Deehan EC; Walter J; Madsen KL
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31557953
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.
Mocanu V; Zhang Z; Deehan EC; Kao DH; Hotte N; Karmali S; Birch DW; Samarasinghe KK; Walter J; Madsen KL
Nat Med; 2021 Jul; 27(7):1272-1279. PubMed ID: 34226737
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation as tool to study the interrelation between microbiota composition and miRNA expression.
Wortelboer K; Bakker GJ; Winkelmeijer M; van Riel N; Levin E; Nieuwdorp M; Herrema H; Davids M
Microbiol Res; 2022 Apr; 257():126972. PubMed ID: 35091345
[TBL] [Abstract][Full Text] [Related]
17. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study.
Wu Z; Zhang B; Chen F; Xia R; Zhu D; Chen B; Lin A; Zheng C; Hou D; Li X; Zhang S; Chen Y; Hou K
Front Cell Infect Microbiol; 2022; 12():1089991. PubMed ID: 36704100
[TBL] [Abstract][Full Text] [Related]
19. Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome.
Koopen AM; Almeida EL; Attaye I; Witjes JJ; Rampanelli E; Majait S; Kemper M; Levels JHM; Schimmel AWM; Herrema H; Scheithauer TPM; Frei W; Dragsted L; Hartmann B; Holst JJ; O'Toole PW; Groen AK; Nieuwdorp M
Front Microbiol; 2021; 12():662159. PubMed ID: 34177842
[TBL] [Abstract][Full Text] [Related]
20. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome.
Holster S; Repsilber D; Geng D; Hyötyläinen T; Salonen A; Lindqvist CM; Rajan SK; de Vos WM; Brummer RJ; König J
Benef Microbes; 2021 Feb; 12(1):17-30. PubMed ID: 33350360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
